Article
Bio-Rad Laboratories Sees FY2026 Sales $2.596B-$2.622B vs $2.630B Est
Full-Year 2026 Financial Outlook
Bio-Rad is providing its financial outlook for the full-year 2026. The Company currently expects non-GAAP, currency neutral revenue growth of approximately 0.5 to 1.5 percent and an estimated non-GAAP operating margin of approximately 12.0 to 12.5 percent.
Comments
- No comments yet. Be the first to comment!